Fas (CD95 or APO-1), a transmembrane cell surface receptor of the tumor necrosis factor receptor family, is up-regulated in activated T lymphocytes. Our present study identified an upstream enhancer element (between nucleotide positions -862 and -682) containing a GA-binding protein (GABP) site and a low affinity activating protein-1 (AP-l)-binding site. T cell activation increased the DNA binding of GABP and AP-1 to this enhancer site. The specificity of GABP and AP-1 binding was demonstrated by competition electrophoretic mobility shift assay and supershift electrophoretic mobility shift assay with antibodies against GABP and AP-1, respectively. Mutational analysis of Fas promoter revealed that both GABP- and AP-l-binding sites were required for initiating Fas gene transcription. We further show that anti-CD3 mAb, phorbol 12-myristate 13-acetate, and phorbol l2-myristate 13-acetate/ionomycin strongly activated promoters carrying multiple copies of the Fas enhancer, and mutation of either the GABP or AP-1 binding site severely reduced transcriptional activity. Taken together, these results suggest that the transcription factors GABP and AP-1 play a critical role in the induction of Fas gene expression in T cell antigen receptor CD3-stimulated Jurkat cells.
机构:
GERMAN CANC RES CTR, DIV IMMUNOGENET, TUMOR IMMUNOL PROGRAMME, D-69120 HEIDELBERG, GERMANYGERMAN CANC RES CTR, DIV IMMUNOGENET, TUMOR IMMUNOL PROGRAMME, D-69120 HEIDELBERG, GERMANY
BEHRMANN, I
;
WALCZAK, H
论文数: 0引用数: 0
h-index: 0
机构:
GERMAN CANC RES CTR, DIV IMMUNOGENET, TUMOR IMMUNOL PROGRAMME, D-69120 HEIDELBERG, GERMANYGERMAN CANC RES CTR, DIV IMMUNOGENET, TUMOR IMMUNOL PROGRAMME, D-69120 HEIDELBERG, GERMANY
WALCZAK, H
;
KRAMMER, PH
论文数: 0引用数: 0
h-index: 0
机构:
GERMAN CANC RES CTR, DIV IMMUNOGENET, TUMOR IMMUNOL PROGRAMME, D-69120 HEIDELBERG, GERMANYGERMAN CANC RES CTR, DIV IMMUNOGENET, TUMOR IMMUNOL PROGRAMME, D-69120 HEIDELBERG, GERMANY
机构:
GERMAN CANC RES CTR, DIV IMMUNOGENET, TUMOR IMMUNOL PROGRAMME, D-69120 HEIDELBERG, GERMANYGERMAN CANC RES CTR, DIV IMMUNOGENET, TUMOR IMMUNOL PROGRAMME, D-69120 HEIDELBERG, GERMANY
BEHRMANN, I
;
WALCZAK, H
论文数: 0引用数: 0
h-index: 0
机构:
GERMAN CANC RES CTR, DIV IMMUNOGENET, TUMOR IMMUNOL PROGRAMME, D-69120 HEIDELBERG, GERMANYGERMAN CANC RES CTR, DIV IMMUNOGENET, TUMOR IMMUNOL PROGRAMME, D-69120 HEIDELBERG, GERMANY
WALCZAK, H
;
KRAMMER, PH
论文数: 0引用数: 0
h-index: 0
机构:
GERMAN CANC RES CTR, DIV IMMUNOGENET, TUMOR IMMUNOL PROGRAMME, D-69120 HEIDELBERG, GERMANYGERMAN CANC RES CTR, DIV IMMUNOGENET, TUMOR IMMUNOL PROGRAMME, D-69120 HEIDELBERG, GERMANY